Kamada, T <br/><br/>
Cetraxate, a mucosal protective agent, combined with omeprazole, amoxycillin, and clarithromycin increases the eradication rate of helicobacter pylori in smokers.  [electronic resource] 

 -  Alimentary pharmacology & therapeutics  Aug 2000 
 - 1089-94 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0269-2813 
<br/><br/><label>Standard No.: </label>10.1046/j.1365-2036.2000.00807.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Amoxicillin--administration & dosage<br/>Anti-Bacterial Agents--administration & dosage<br/>Anti-Ulcer Agents--administration & dosage<br/>Clarithromycin--administration & dosage<br/>Double-Blind Method<br/>Drug Therapy, Combination<br/>Female<br/>Gastric Mucosa--blood supply<br/>Helicobacter Infections--drug therapy<br/>Helicobacter pylori--drug effects<br/>Humans<br/>Male<br/>Middle Aged<br/>Omeprazole--administration & dosage<br/>Penicillins--administration & dosage<br/>Regional Blood Flow<br/>Smoking<br/>Tranexamic Acid--administration & dosage<br/>Treatment Outcome